Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15094648rdf:typepubmed:Citationlld:pubmed
pubmed-article:15094648lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:15094648lifeskim:mentionsumls-concept:C1533685lld:lifeskim
pubmed-article:15094648lifeskim:mentionsumls-concept:C0014591lld:lifeskim
pubmed-article:15094648lifeskim:mentionsumls-concept:C0039445lld:lifeskim
pubmed-article:15094648lifeskim:mentionsumls-concept:C0444498lld:lifeskim
pubmed-article:15094648lifeskim:mentionsumls-concept:C0116757lld:lifeskim
pubmed-article:15094648pubmed:issue2lld:pubmed
pubmed-article:15094648pubmed:dateCreated2004-4-19lld:pubmed
pubmed-article:15094648pubmed:abstractTextAfter a brief review of Rendu-Osler-Weber disease, we present the results from a series of 13 patients treated by Ethibloc injections for epistaxis. Based on a review of the literature, typical treatments are presented along with discussion of their efficacy and side effects. In our series, 90% of patients improved after only one injection. All patients reported a decrease in hemorrhage, especially patients with recurrent epistaxis. Five of nine patients reported a decrease in the length of the bleeding episodes. Improvement was reported by 85% of patients within one month following Ethibloc injection. Fifty percent of these patients have persistent good results at 4 Year follow-up. Our results indicate that Ethibloc injections are safe and effective as an alternative treatment for patients that have failed standard treatment options.lld:pubmed
pubmed-article:15094648pubmed:languageenglld:pubmed
pubmed-article:15094648pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15094648pubmed:citationSubsetIMlld:pubmed
pubmed-article:15094648pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15094648pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15094648pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15094648pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15094648pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15094648pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15094648pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15094648pubmed:statusMEDLINElld:pubmed
pubmed-article:15094648pubmed:monthMarlld:pubmed
pubmed-article:15094648pubmed:issn0150-9861lld:pubmed
pubmed-article:15094648pubmed:authorpubmed-author:DubinJJlld:pubmed
pubmed-article:15094648pubmed:authorpubmed-author:LaccourreyeLLlld:pubmed
pubmed-article:15094648pubmed:authorpubmed-author:Pasco-PaponAAlld:pubmed
pubmed-article:15094648pubmed:authorpubmed-author:Roux-Vaillard...lld:pubmed
pubmed-article:15094648pubmed:issnTypePrintlld:pubmed
pubmed-article:15094648pubmed:volume31lld:pubmed
pubmed-article:15094648pubmed:ownerNLMlld:pubmed
pubmed-article:15094648pubmed:authorsCompleteYlld:pubmed
pubmed-article:15094648pubmed:pagination110-5lld:pubmed
pubmed-article:15094648pubmed:dateRevised2008-2-20lld:pubmed
pubmed-article:15094648pubmed:meshHeadingpubmed-meshheading:15094648...lld:pubmed
pubmed-article:15094648pubmed:meshHeadingpubmed-meshheading:15094648...lld:pubmed
pubmed-article:15094648pubmed:meshHeadingpubmed-meshheading:15094648...lld:pubmed
pubmed-article:15094648pubmed:meshHeadingpubmed-meshheading:15094648...lld:pubmed
pubmed-article:15094648pubmed:meshHeadingpubmed-meshheading:15094648...lld:pubmed
pubmed-article:15094648pubmed:meshHeadingpubmed-meshheading:15094648...lld:pubmed
pubmed-article:15094648pubmed:meshHeadingpubmed-meshheading:15094648...lld:pubmed
pubmed-article:15094648pubmed:meshHeadingpubmed-meshheading:15094648...lld:pubmed
pubmed-article:15094648pubmed:meshHeadingpubmed-meshheading:15094648...lld:pubmed
pubmed-article:15094648pubmed:meshHeadingpubmed-meshheading:15094648...lld:pubmed
pubmed-article:15094648pubmed:meshHeadingpubmed-meshheading:15094648...lld:pubmed
pubmed-article:15094648pubmed:meshHeadingpubmed-meshheading:15094648...lld:pubmed
pubmed-article:15094648pubmed:meshHeadingpubmed-meshheading:15094648...lld:pubmed
pubmed-article:15094648pubmed:meshHeadingpubmed-meshheading:15094648...lld:pubmed
pubmed-article:15094648pubmed:meshHeadingpubmed-meshheading:15094648...lld:pubmed
pubmed-article:15094648pubmed:meshHeadingpubmed-meshheading:15094648...lld:pubmed
pubmed-article:15094648pubmed:meshHeadingpubmed-meshheading:15094648...lld:pubmed
pubmed-article:15094648pubmed:year2004lld:pubmed
pubmed-article:15094648pubmed:articleTitleTreatment of epistaxis in Rendu-Osler-Weber disease by in situ Ethibloc injections.lld:pubmed
pubmed-article:15094648pubmed:affiliationService d'Oto-Rhino-Laryngologie et de Chirurgie Cervico-Faciale, Centre Hospitalier et Universitaire d'Angers, 49033 Angers cedex 01, France. sroux-vaillard@libertysurf.frlld:pubmed
pubmed-article:15094648pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15094648pubmed:publicationTypeEvaluation Studieslld:pubmed